(Total Views: 48)
Posted On: 03/07/2017 10:51:28 AM
Post# of 89539
$ADMD Advanced Medical Isotope Corporation ("AMI"
(OTC PINK: ADMD), a cancer therapeutics company focused on the commercialization of their RadioGelâ„¢ device, a tumor-injectable and biodegradable radiation that remains focused at the treatment site, today released the third letter in a four letter series outlining AMI's push towards FDA submittal and commercialization from its new President & CEO, Dr. Mike Korenko.
Advanced Medical Isotope's CEO Releases Shareholder Letter Announcing and Discussing their Cancer Indication Selection to Pursue for FDA Approval http://finance.yahoo.com/news/advanced-medica...00345.html
(OTC PINK: ADMD), a cancer therapeutics company focused on the commercialization of their RadioGelâ„¢ device, a tumor-injectable and biodegradable radiation that remains focused at the treatment site, today released the third letter in a four letter series outlining AMI's push towards FDA submittal and commercialization from its new President & CEO, Dr. Mike Korenko. Advanced Medical Isotope's CEO Releases Shareholder Letter Announcing and Discussing their Cancer Indication Selection to Pursue for FDA Approval http://finance.yahoo.com/news/advanced-medica...00345.html
(0)
(0)
